Anton Hagenbeek, Hans Mooij, Josée Zijlstra, Pieternella Lugtenburg, Gustaaf van Imhoff, Marcel Nijland, Sanne Tonino, Martin Hutchings, Marjolein Spiering, Roberto Liu, Harm van Tinteren, and Marie José Kersten. 2019. “Phase I Dose-Escalation Study of Brentuximab-Vedotin Combined With Dexamethasone, High-Dose Cytarabine and Cisplatin, As Salvage Treatment in relapsed/Refractory Classical Hodgkin Lymphoma: The HOVON/LLPC Transplant BRaVE Study”. Haematologica 104 (4). Pavia, Italy, e151-e153. https://doi.org/10.3324/haematol.2018.196899.